Immunogenicity of therapeutic proteins.
Schellekens
Huub
H
Central Laboratory Animal Institute and Department of Innovation Studies, Utrecht University, The Netherlands. h.schellekens@gdl.uu.nl
D004921:Erythropoietin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D006801:Humans; D007125:Immunogenetics; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000188:drug therapy* / Q000235:genetics / Q000276:immunology*; D012010:Red-Cell Aplasia, Pure / Q000139:chemically induced* / Q000235:genetics / Q000276:immunology*; D012646:Self Administration / Q000009:adverse effects
D004921:Erythropoietin